Pages that link to "Q67857392"
Jump to navigation
Jump to search
The following pages link to hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses (Q67857392):
Displaying 34 items.
- Bone anabolic effects of separate and combined therapy with growth hormone and parathyroid hormone on femoral neck in aged ovariectomized osteopenic rats (Q30650840) (← links)
- Effects of separate and combined therapy with growth hormone and parathyroid hormone on lumbar vertebral bone in aged ovariectomized osteopenic rats (Q30653087) (← links)
- A role for parathyroid hormone-related protein in the pathogenesis of inflammatory/autoimmune diseases (Q34283353) (← links)
- The use of intermittent human parathyroid hormone as a treatment for osteoporosis (Q35624601) (← links)
- Combination/sequential therapy in osteoporosis (Q36203344) (← links)
- Does early PTH treatment compromise bone strength? The balance between remodeling, porosity, bone mineral, and bone size (Q36203360) (← links)
- Canadian Consensus Conference on osteoporosis, 2006 update. (Q36454421) (← links)
- Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study. (Q36817240) (← links)
- Adaptation to vitamin D deficiency: Age specific clinical presentations. (Q37201620) (← links)
- Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial (Q37385973) (← links)
- Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis Therapy (Q39183207) (← links)
- Using Osteoporosis Therapies in Combination (Q39408210) (← links)
- Bone formation with disruption of the lamina dura in the mandibular third molar. (Q40352828) (← links)
- Advantages of concurrent use of anabolic and antiresorptive agents over single use of these agents in increasing trabecular bone volume, connectivity, and biomechanical competence of rat vertebrae (Q40786772) (← links)
- Parathyroid hormone in the treatment of involutional osteoporosis: back to the future. (Q40909120) (← links)
- Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits (Q43601708) (← links)
- The rhPTH treatment elevates plasma secreted protein acidic and rich in cysteine levels in patients with osteoporosis (Q44429940) (← links)
- Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure (Q46250682) (← links)
- Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34). (Q46289309) (← links)
- Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis (Q46289900) (← links)
- Decreased cortical and increased cancellous bone in two children with primary hyperparathyroidism (Q46877313) (← links)
- Development and validation of RP-HPLC and RP-UPLC methods for quantification of parathyroid hormones (1-34) in medicinal product formulated with meta-cresol (Q49868656) (← links)
- Effect of treatment for 6 months with human parathyroid hormone (1-34) peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis). (Q54078325) (← links)
- Optimizing Sequential and Combined Anabolic and Antiresorptive Osteoporosis Therapy (Q57147876) (← links)
- Human parathyroid peptide treatment of vertebral osteoporosis (Q70631996) (← links)
- Truncation of the amino terminus of PTH alters its anabolic activity on bone in vivo (Q71786700) (← links)
- Restoration of severely depleted femoral trabecular bone in ovariectomized rats by parathyroid hormone-(1-34) (Q72236193) (← links)
- No loss of biomechanical effects after withdrawal of short-term PTH treatment in an aged, osteopenic, ovariectomized rat model (Q73327490) (← links)
- Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis) (Q73448303) (← links)
- Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis (Q73668443) (← links)
- Anabolic therapies (Q74313482) (← links)
- Effects of a weekly injection of human parathyroid hormone (1-34) and withdrawal on bone mass, strength, and turnover in mature ovariectomized rats (Q74587795) (← links)
- Influence of a low calcium and phosphorus diet on the anabolic effect of human parathyroid hormone (1-38) in female rats (Q74609174) (← links)
- Biologicals in osteoporosis: teriparatide and parathyroid hormone in women and men (Q84444255) (← links)